Name:
GM-CSF Protein
Synonyms:
GM-CSF, Granulocyte Macrophage Colony Stimulating Factor, CSF-2, MGI-1GM, Pluripoietin-alpha, Molgramostin, Sargramostim Ala18-Glu144
Species Name:
Human
Label Name:
No Tag
Marker Name:
Unconjugated
Accession:
P04141
Gene Id:
Ala18-Glu144 MAPARSPSPSTQPWEHVNAIQEARRLLNLSRDTAAEMNETVEVISEMFDLQEPTCLQTRLELYKQGLRGSLTKLKGPLTMMASHYKQHCPPTPETSCATQIITFESFKENLKDFLLVIPFDCWEPVQE
Molecular Weight:
15kDa (Reducing)
Purity:
>95% by SDS-PAGE
Physical Appearance Name:
Lyophilized Powder
Endotoxin Name:
<0.1EU/μg
Reconstitution:
Reconstitute at 0.1-1 mg/ml according to the size in ultrapure water after rapid centrifugation.\n
Stability Storage:
·12 months from date of receipt, -20 to -70 °C as supplied. ·1 month, 2 to 8 °C under sterile conditions after reconstitution. ·Please avoid repeated freeze-thaw cycles.
Buffer System:
20mM Tris, 100mM NaCl, pH8.0
Quality Statement:
Granulocyte-macrophagecolony-stimulating factor (GM-CSF), also known as colony-stimulating factor 2(CSF2), is a monomeric glycoprotein secreted by macrophages, T cells, mastcells, natural killer cells, endothelial cells and fibroblasts that functionsas a cytokine. GM-CSF was first described as a growth factor that induces thedifferentiation and proliferation of myeloid progenitors in the bone marrow,which also has an important cytokine effect in chronic inflammatory diseases bystimulating the activation and migration of myeloid cells to inflammationsites, promoting survival of target cells and stimulating the renewal ofeffector granulocytes and macrophages. GM-CSF receptor is composed of one αchain and one β chain with low and high-affinity binding to GM-CSF,respectively, and the β chain is shared with IL-3 and IL-5 receptor. GM-CSFsignals via signal transducer and activator of transcription, STAT5. Inmacrophages, it has also been shown to signal via STAT3. The cytokine activatesmacrophages to inhibit fungal survival.
Reference:
1.Robertson S A. (2007) GM-CSF regulation of embryodevelopment and pregnancy. Cytokine Growth Factor Rev. 18(3-4): 287-298.2.Waller E K. (2007) The role of sargramostim (rhGM-CSF)as immunotherapy. Oncologist. 12: 22-26.3.Clive K S. et al. (2010) Use of GM-CSF as anadjuvant with cancer vaccines: beneficial or detrimental? Expert Rev Vaccines.9(5): 519-525.
Related category websites: https://www.medchemexpress.com/recombinant-proteins.html
Popular product recommendations:
Esterase D/FGH Protein
TL1A/TNFSF15 Protein
Popular categories:
TPO-R/CD110
ILT-7/CD85g